- All > Medicine Information and Evidence for Policy > Information and Publications
- All > Medicine Access and Rational Use > Rational Use
- All > Medicine Access and Rational Use > Supply Management
- Keywords > drug supply
- Keywords > essential medicines - concept
- Keywords > Essential Medicines List (EML)
- Keywords > generic medicines/brand name medicines - comparative evaluation
- Keywords > generic substitution
- Keywords > local pharmaceutical industry
- Keywords > national medicines policy - development
- Keywords > national pharmaceutical policy
- Keywords > quality control
- Keywords > quantification - pharmaceutical requirements
(1987; 12 pages) [French] [Spanish]
The fourth issue of the Essential Drugs Monitor examines the role of pharmaceuticals as part of the World Health Organization’s Essential Drugs Programme. In one article, the United States Food and Drug Administration refutes ten common myths about generic medicines and describes recent American legislation on pharmaceuticals. Another article describes new guidelines that have been implemented in the State of Victoria, Australia for effective, economical, and conservative use of antibiotics. A third article describes the background and methodology of a study being conducted by Dr. Anita Hardon on how modern pharmaceuticals are used in two poor urban communities in the Philippines.
The major report in this issue is a two-page feature highlighting the seven key steps for success in supplying essential drugs. As defined by the WHO, the seven key components to essential drugs supply are national drug policy, careful selection of essential drugs, drug procurement, functional supply logistics, rational use, quality control, and health care worker training. The feature describes each step and serves as a guide for nations wishing to apply the essential drugs concept in their country. This Monitor also includes short articles on several programs being partially sponsored by WHO such as emergency immunization kits tested in Somalia and quality control workshops from the International Federation of Pharmaceutical Manufacturers’ Associations and the World Federation of Proprietary Medicine Manufacturers.
Other notable articles in this Monitor include a report of the issue of drug requirement quantification in Burundi and an interview with Dr. Zafrullah Chowdhury, co-founder of Gonoshasthaya Kendra (People’s Health Centre) in Bangladesh. The interview focused on the Centre’s essential drugs factory and the role of generic medicines in Bangladesh. The Newsdesk includes stories on the National Drug Formulary in Nicaragua, the creation of a national drug policy in Yemen Arab Republic, and the launch of a Regional Pharmaceuticals Project by the Organization of Eastern Caribbean States. The Newsdesk also mentions the Fourth Commonwealth Pharmaceutical Association Conference and an international symposium on Essential Drugs in Developing Countries that will be held later in 1987.